NEUROPACE INC. - COMMON STOCK

NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results

10 3 2022 15:02:00 提供 Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference 

27 1 2022 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

11 1 2022 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference

16 12 2021 06:00:00 提供 Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2021 Financial Results

10 11 2021 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy

10 11 2021 15:02:00 提供 Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021

20 10 2021 15:05:00 提供 Nasdaq GlobeNewswire

NeuroPace Announces Addition of Lisa Andrade to the Board

19 10 2021 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Conferences

23 8 2021 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2021 Financial Results

12 8 2021 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021

22 7 2021 15:03:00 提供 Nasdaq GlobeNewswire

NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome

30 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

03 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

20 5 2021 07:00:01 提供 Nasdaq GlobeNewswire

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

26 4 2021 15:05:00 提供 Nasdaq GlobeNewswire